Come up with a name for your new list and we'll add to it:
Neoantigenics raised a round of funding on April 12, 2014. Investors include
CIT GAP Funds.
Neoantigenics is focused on developing oncology theranostics (therapeutic plus diagnostic) products, founded on the novel science around oocyte (egg)-associated cancer neoantigens discovered at the Un…